Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 1.58% and Operating profit at -7.20% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- OPERATING PROFIT TO INTEREST (Q) Lowest at 7.01 times
- CASH AND CASH EQUIVALENTS(HY) Lowest at EUR 1,148.00 MM
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.87 times
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-55.4%
0%
-55.4%
6 Months
-41.28%
0%
-41.28%
1 Year
-45.61%
0%
-45.61%
2 Years
-49.32%
0%
-49.32%
3 Years
-58.49%
0%
-58.49%
4 Years
-51.21%
0%
-51.21%
5 Years
-55.61%
0%
-55.61%
Fresenius Medical Care AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.72%
EBIT Growth (5y)
-5.73%
EBIT to Interest (avg)
4.39
Debt to EBITDA (avg)
2.10
Net Debt to Equity (avg)
0.44
Sales to Capital Employed (avg)
0.82
Tax Ratio
33.92%
Dividend Payout Ratio
78.55%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
8.54%
ROE (avg)
8.48%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.03
EV to EBIT
12.42
EV to EBITDA
6.19
EV to Capital Employed
1.02
EV to Sales
1.02
PEG Ratio
14.11
Dividend Yield
3.10%
ROCE (Latest)
8.20%
ROE (Latest)
7.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Mar 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
4,791.70
4,881.00
-1.83%
Operating Profit (PBDIT) excl Other Income
759.50
785.00
-3.25%
Interest
96.60
96.00
0.63%
Exceptional Items
-11.70
0.00
Consolidate Net Profit
272.30
189.00
44.07%
Operating Profit Margin (Excl OI)
82.90%
79.90%
0.30%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -1.83% vs -4.01% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 44.07% vs 60.17% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
19,337.70
19,454.10
-0.60%
Operating Profit (PBDIT) excl Other Income
3,179.60
3,200.00
-0.64%
Interest
397.10
409.90
-3.12%
Exceptional Items
-487.20
-294.40
-65.49%
Consolidate Net Profit
740.90
732.50
1.15%
Operating Profit Margin (Excl OI)
85.00%
81.60%
0.34%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -0.60% vs 0.30% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 1.15% vs -18.09% in Dec 2023
About Fresenius Medical Care AG 
Fresenius Medical Care AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






